Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society


Sumit Parikh MD, Amy Goldstein MD, Amel Karaa MD, Mary Kay Koenig MD, Irina Anselm MD, Catherine Brunel-Guitton MD, FRCPC, John Christodoulou MBBS, PhD, Bruce H Cohen MD, David Dimmock MD, Gregory M Enns MD, ChB, Marni J Falk MD, Annette Feigenbaum MD, Richard E Frye MD, PhD, Jaya Ganesh MD, David Griesemer MD, Richard Haas MRCP, Rita Horvath MD, PhD, Mark Korson MD, Michael C Kruer MD, Michelangelo Mancuso MD, PhD, Shana McCormack MD, Marie Josee Raboisson MD, Tyler Reimschisel MD, MHPE, Ramona Salvarinova MD, FRCPC, Russell P Saneto DO, PhD, Fernando Scaglia MD, John Shoffner MD, Peter W Stacpoole PhD, MD, Carolyn M Sue MBBS, PhD, Mark Tarnopolsky MD, PhD, Clara Van Karnebeek MD, PhD, Lynne A Wolfe MS, CRNP, Zarazuela Zolkipli Cunningham MBChB, MRCP, Shamima Rahman FRCP, PhD & Patrick F Chinnery FRCP, FMedSci

The purpose of this statement is to provide consensus-based recommendations for optimal management and care for patients with primary mitochondrial disease. This statement is intended for physicians who are engaged in the diagnosis and management of these patients. Working group members were appointed by the Mitochondrial Medicine Society. The panel included members with several different areas of expertise. The panel members utilized surveys and the Delphi method to reach consensus. We anticipate that this statement will need to be updated as the field continues to evolve. Consensus-based recommendations are provided for the routine care and management of patients with primary genetic mitochondrial disease.

Published: 27 July 2017
Journal: Genetics in Medicine, volume 19, pages 1380


The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit